JP:130A Stock Latest News
Company AnnouncementsVeritas In Silico Hits Key Milestone in Toray mRNA Drug Discovery Collaboration6d ago130A
Company AnnouncementsVeritas In Silico Expands mRNA Partnerships as ALS Drug and Delivery Pipeline Advance2M ago130A
Company AnnouncementsVeritas In Silico Widens Losses as Revenue Slips and Equity Declines2M ago130A
Company AnnouncementsVeritas In Silico and MGC File First-in-Class lncRNA Cancer Drug Patent2M ago130A
Company AnnouncementsVeritas In Silico Reshapes Research Leadership With Executive Officer Change3M ago130A
Company AnnouncementsVeritas In Silico and SpiroChem Sign Joint Pact on Next-Generation mRNA Drugs5M ago130ACompany AnnouncementsVeritas In Silico Deepens mRNA Drug Partnerships as Loss Widens in Q1 FY20265M ago130A
Company AnnouncementsVeritas In Silico Books ¥135 Million Impairment, Keeps 2026 Outlook Intact5M ago130A
Company AnnouncementsVeritas In Silico Widens Quarterly Losses but Keeps 2026 Outlook Unchanged5M ago130A
Company AnnouncementsVeritas In Silico Ends mRNA Drug Discovery Collaboration with Takeda6M ago130A
Company AnnouncementsVeritas In Silico Revamps Board and Audit Lineup Ahead of 10th AGM8M ago130A
Company AnnouncementsVeritas In Silico Unveils AI-Driven Strategy to Become Specialty Pharma Leader8M ago130A
Company AnnouncementsVeritas In Silico Issues Fiscal 2025 Results With Caution on Forward-Looking Statements8M ago130ACompany AnnouncementsVeritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs9M ago130A
- Company AnnouncementsVeritas In Silico and Jikei University Secure Patent Publication for Novel ALS Nucleic Acid Therapy9M ago130A
- Company AnnouncementsVeritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury10M ago130A
- Company AnnouncementsVeritas In Silico’s Strategic Shift Towards Specialty Pharma10M ago130A
- Company AnnouncementsVeritas In Silico Secures Patent for Innovative Drug Delivery System10M ago130A
Company AnnouncementsVeritas In Silico Partners with Shimane University for Post-Transplant Drug Development11M ago130A
